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Ethnopharmacological relevance: Turraea robusta and Turraea nilotica are African medicinal plants used
for the treatment of a wide variety of diseases, including malaria. The genus Turraea is rich in limonoids
and other triterpenoids known to possess various biological activities.
Materials and methods: From the stem bark of T. robusta six compounds, and from various parts of T.
nilotica eleven compounds were isolated by the use of a combination of chromatographic techniques. The
structures of the isolated compounds were elucidated using NMR and MS, whilst the relative conﬁg-
uration of one of the isolated compounds, toonapubesin F, was established by X-ray crystallography. The
antiplasmodial activities of the crude extracts and the isolated constituents against the D6 and W2
strains of Plasmodium falciparum were determined using the semiautomated micro dilution technique
that measures the ability of the extracts to inhibit the incorporation of (G-3H, where G is guanine) hy-
poxanthine into the malaria parasite. The cytotoxicity of the crude extracts and their isolated con-
stituents was evaluated against the mammalian cell lines African monkey kidney (vero), mouse breast
cancer (4T1) and human larynx carcinoma (HEp2).
Results: The extracts showed good to moderate antiplasmodial activities, where the extract of the stem
bark of T. robustawas also cytotoxic against the 4T1 and the HEp2 cells (IC50o10 μg/ml). The compounds
isolated from these extracts were characterized as limonoids, protolimonoids and phytosterol glucosides.
These compounds showed good to moderate activities with the most active one being azadironolide, IC50
2.470.03 μM and 1.170.01 μM against the D6 and W2 strains of Plasmodium falciparum, respectively;
all other compounds possessed IC50 14.4–40.5 μM. None of the compounds showed signiﬁcant cyto-
toxicity against vero cells, yet four of them were toxic against the 4T1 and HEp2 cancer cell lines with
piscidinol A having IC50 8.070.03 and 8.4 70.01 μM against the 4T1 and HEp2 cells, respectively.
Diacetylation of piscidinol A resulted in reduced cytotoxicity.
Conclusion: From the medicinal plants T. robusta and T. nilotica, twelve compounds were isolated and
characterized; two of the isolated compounds, namely 11-epi-toonacilin and azadironolide showed good
antiplasmodial activity with the highest selectivity indices.
& 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The genus Turraea (family Meliaceae) consists of circa 70 spe-
cies, mainly shrubs and small trees, and is widely distributed inIreland Ltd. This is an open acces
sew),Eastern Africa. Several of its species are used in indigenous med-
icine for the treatment of gastrointestinal disorders (Kokwaro,
2009). For example T. ﬂoribunda is used as an emetic and purga-
tive, T. holstii is used to treat diarrhea and constipation, and T.
mombassana against excess bile, malaria and other fevers. Turraea
robusta is utilized to treat malaria, stomach pain, diarrhea and
gastrointestinal discomfort (Gathirwa et al., 2008; Kokwaro, 2009).
Its leaves are used as an antidote for poisoning. The roots ofs article under the CC BY-NC-ND license
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orders in traditional medicine (Kokwaro, 2009).
The methanolic root bark extract of T. robusta was previously
reported to possess antiplasmodial and antimalarial activities,
with negligible toxicity (mice oral LD5045000 mg/kg body
weight) (Irungu et al., 2007; Gathirwa et al., 2008). Previous
phytochemical investigations of the root bark of T. robusta led to
the isolation of triterpenoids which included ﬁve limonoids (Rajab
et al., 1988; Bentley et al., 1992). There are no phytochemical and
antiplasmodial reports on the stem bark of T. robusta. Investigation
of the root and stem bark of T. nilotica led to the identiﬁcation of a
limonoid and three protolimonoids (Mulholland and Taylor, 1988;
Bentley et al., 1995). However these compounds were not eval-
uated for their antiplasmodial and cytotoxic properties. In our
search for plant secondary metabolites with potential anti-
plasmodial activities, the crude extracts and the isolated second-
ary metabolites of T. nilotica Kotschy and Peyr, and of T. robusta
Gürke were tested against the chloroquine resistant (W2) and the
chloroquine sensitive (D6) strains of Plasmodium falciparum. In
addition, their cytotoxicity against three mammalian cell lines,
African green monkey kidney (vero), mouse breast cancer (4T1)
and human larynx carcinoma (HEp2) was evaluated. Here, the
isolation and the characterization of the constituents of these
plants as well as their antiplasmodial and cytotoxic activities are
reported.2. Materials and Methods
The stem bark of T. robusta Gürke (BN/2011/1) was collected
from Chiromo Campus (01°16’31.34”S; 036°38’64”E) of the Uni-
versity of Nairobi in July 2011. The leaves, stem and root bark of T.
nilotica Kotschy & Peyr. (BN/2012/1) were collected from the
Mombasa Diani area (039°38’17.06”E; 04°19’04.72”S) in February
2012. The plants were authenticated by Mr. Patrick Mutiso of the
Herbarium, School of Biological Science, University of Nairobi
where voucher specimens were deposited.
2.1. Antiplasmodial assay
Continuous in vitro cultures of asexual erythrocytic stages of P.
falciparum strains (W2 and D6) were maintained following pre-
viously described procedures (Kigondu et al., 2009). A drug assay
was carried out following a modiﬁcation of the semiautomated
micro dilution technique that measures the ability of the extracts
to inhibit the incorporation of (G-3H) hypoxanthine into the ma-
laria parasite (Gathirwa et al., 2008). Plates were harvested onto
glass ﬁber ﬁlters and hypoxanthine (G-3H) uptake determined
using a micro-beta trilux liquid scintillation and luminescence
counter (Wallac, MicroBeta TriLux) and results recorded as counts
per minute (cpm) per well at each drug concentration. Data was
transferred into Microsoft Excel 2007, and expressed as percentage
of the untreated controls. Results were expressed as the drug
concentration required for 50% inhibition of (G-3H) hypoxanthine
incorporation into parasite nucleic acid, using a non-linear re-
gression analysis of the dose–response curve. The criterion for
scoring activity of compounds described by Batista et al. (2009)
was adopted: IC50o1 μM, highly active; IC50Z1 and o20 μM,
active; IC50Z20-100 μM, moderate activity; IC504100 inactive.
2.2. Cytotoxicity assay
Rapid colorimetric assay was carried out using 3-(4,5-di-
methylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)
(Mosmann, 1983). This assay is based on the ability of a mi-
tochondrial dehydrogenase enzyme of viable cells to cleave thetetrazolium rings of the pale yellow MTT and thereby form dark
blue formazan crystals, which are largely impermeable to cell
membranes, resulting in their accumulation within healthy cells.
The amount of generated formazan is directly proportional to the
number of cells (Mosmann, 1983). In this assay, the mammalian
cell lines African monkey kidney (vero), mouse breast cancer (4T1)
and human larynx carcinoma (HEp2) were used. Cells were
maintained in Eagle’s Minimum Essential Medium (MEM) con-
taining 10% fetal bovine serum (FBS). A cell density of 20,000 cells
per well in 100 μL serum were seeded on 96-well plates and in-
cubated for 12 h at 37 °C and 5% CO2 to attach to the surface.
Following 12 h, the medium was replaced with maintenance
medium containing the appropriate drug concentration, 0.14–
100 μg/mL, or vehicle control (r1.0% v/v DMSO). After an in-
cubation of 48 h, cell viability was measured by addition of 10 mL
of MTT reagent (5 mg MTT in 1 ml of PBS). The plates were in-
cubated for an additional 4hours at the same conditions. Next, all
media was removed from the plates and 100 mL DMSO was added
to dissolve the formazan crystals. The plates were read on a
Multiskan EX Labsystems scanning multi-well spectrophotometer
at 562 nm, and 620 nm as reference. The results were recorded as
optical density (OD) per well at each drug concentration, the data
was transferred into the software Microsoft Excel 2007 and ex-
pressed as percentage of the untreated controls. Percentage cyto-
toxicity (PC) as compared to the untreated controls was calculated
using the following equation:
⎡
⎣⎢
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where A is the mean OD of the untreated cells and B is the mean
OD at each drug concentration. The drug concentration required
for 50% inhibition of cell growth, using nonlinear regression ana-
lysis of the dose–response curve, was calculated. Cytotoxicity was
deﬁned as toxic if IC50o100 ug/ml.
2.3. Extraction and Isolation
2.3.1. Turraea robusta
The air dried and ground stem bark of T. robusta (1.4 kg) was
extracted with MeOH/CH2Cl2 (1:1) at room temperature (23 L,
48 h each). The ﬁltrate was dried in vacuo using a rotary eva-
porator to yield dark red oil (144 g). A 79 g portion of the extract
was fractionated using silica gel column chromatography (600 g,
5 cm30 cm) with gradient elution of petroleum ether (40–60 °C)
and increasing proportions of ethyl acetate. A total of 41 eluents,
ca. 250 mL each, were collected and combined into 11 fractions,
labeled TR1-TR11 on the basis of their TLC proﬁles. Fraction
TR4 (1.2 g) was re-chromatographed over silica gel (10 g,
2 cm30 cm) using petroleum ether/acetone (95:5) to yield aza-
dirone (1, 32.4 mg). Fraction TR7 (4.0 g) was fractionated on
SephadexR LH-20 (40 g, 2 cm30 cm) eluting with methanol and
was further puriﬁed by PTLC eluting with petroleum ether/
chloroform/methanol (16:2:1) to yield 12α-acetoxy-7-deacetyla-
zadirone (2, 7.0 mg) and mzikonone (3, 6.3 mg). Fraction TR8
(3.0 g) was re-chromatographed on silica gel column (30 g,
2 cm cm) eluting with petroleum ether/ethyl acetate (9:1) and a
subfraction containing one major compound was puriﬁed on PTLC,
eluting with petroleum ether/acetone (7:4) to yield azadironolide
(5, 16.5 mg). Fractions TR9-10 were combined (145.2 mg) and were
separated on PTLC eluting with petroleum ether/chloroform/me-
thanol (10:2:1) yielding 11-epi-toonacilin (4, 3.0 mg). The pur-
iﬁcation of fraction TR11 (331.9 mg) on PTLC using petroleum
ether/chloroform/methanol (12:2:1) eluent gave turranolide (6,
17.7 mg).
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The air dried and grounded stem bark of T. nilotica (1.2 kg) was
extracted and dried following the procedure described in Section
2.3.1. to yield a dark gum (59 g). A 58 g portion of the extract was
fractionated by silica gel column chromatography (400 g,
5 cm30 cm) using petroleum ether (40-60 °C) and increasing
proportions of ethyl acetate as eluent. A total of 50 fractions, ca.
250 mL each, were collected and combined into 20 major fractions,
labeled TN1-20, upon TLC analyses. Repeated silica gel column
chromatography (10 g, 2 cm30 cm) of fraction TN12 (1.35 g)
eluting with 9:1 petroleum ether/acetone yielded niloticin (8,
9.3 mg). Fractions TN13-15 (7 g) were combined and puriﬁed by
silica gel column chromatography (100 g, 230 cm) using petro-
leum ether and increasing portions of acetone; crystallization of
the residue from an acetone/dichloromethane mixture yielded
toonapubesin F (11, 20.1 mg). A repeated column chromatographic
(30 g, 2 cm30 cm) separation of fraction TN16 (3 g) in silica gel
followed by crystallization from a methanol/dichloromethane
mixture yielded piscidinol A (10, 775.6 mg). Fraction TN18 was
crystallized from methanol/dichloromethane (1:9) to yield hispi-
dol B (9, 84.2 mg).
The root bark of T. nilotica (837 g) was extracted and dried as
described in Section 2.3.1 above yielding 13 g of a yellowish gum.
A portion of the extract (11 g) was fractionated by silica gel column
chromatography (88 g, 2 cm30 cm) using a petroleum ether:
acetone gradient, with increasing polarity. Forty six fractions, ca.
100 mL each, were collected and combined into 20 major fractions,
labeled TN21-40, based on their TLC proﬁle. Fraction TN27
(140.7 mg) was puriﬁed on PTLC eluting with petroleum ether/
acetone (9:1) to yield azadirone (1, 8.3 mg). Fraction TN32
(366 mg) was subjected to RP-HPLC (CH3OH/water) yielding 12α-
acetoxy-7-deacetylazadirone (2, 18.5 mg) and mzikonone (3,
4.4 mg). Repeated column chromatographic puriﬁcation of fraction
TN36 (358 mg) followed by PTLC with a petroleum ether/chloro-
form/methanol (10:2:1) mixture as eluent yielded 1α,3α-diacetyl-
7α-tigloyvilasinin (7, 11.6 mg).
The dried and grounded leaves of T. nilotica (500 g) were ex-
tracted as described in Section 2.3.1, yielding 30 g of a dark green
gum. A 20 g portion of the crude extract was fractionated using
silica gel column chromatography (200 g, 5 cm30 cm) with
petroleum ether/acetone gradient with increasing polarity. A total
of ﬁfty eight fractions, ca 100 mL each, were collected and com-
bined into the 12 major fractions and labeled TN41-52, based on
TLC proﬁling. Fraction TN43 was crystallized from acetone giving
β-sitosterol (15) and stigmasterol (16) as a mixture (4.7 mg).
Fraction TN50 was crystallized from acetone yielding sitosterol
3- O-β-D-glucopyranoside acetate (12) and stigmasterol-3- O-β-D-
glucopyranoside acetate (13) as a mixture (9.8 mg). Fraction TN52
was crystallized in acetone to yield sitosterol-3- O-β-D-glucopyr-
anoside (14, 4.7 mg).
2.3.3. Structure elucidation
For structure elucidation 1H, 13C, gCOSY, gNOESY, gHSQC and
gHMBC NMR spectra were acquired on an Bruker Avance III HD
800 MHz, on a Varian VNMR-S 500 or a Varian 400 MR spectro-
meter. The spectra were processed using the MestReNova (v9.0.0)
software. Chemical shifts were referenced indirectly to tetra-
methylsilane via the residual solvent signal (CHCl3, 1H at 7.26 ppm
and 13C at 77.16 ppm). LC(ESI)MS spectra was acquired on a PE
SCIEX API 150EX instrument (Perkin Elmer, Waltham, MA, USA)
equipped with a Turbolon spray ion source (30 eV ionization en-
ergy) and a Gemini 5 mmC-18 110 Å HPLC column, using water:
acetonitrile gradient (80:20 to 20:80).2.4. X-ray diffraction
Crystals of compound 11 was selected and mounted under a
stereo microscope on to a glass ﬁber and transferred to a Rigaku
R-AXIS IIc image plate system. Diffracted intensities were mea-
sured using graphite-monochromated Mo Kα (λ¼0.710 73 Å) ra-
diation from a RU-H3R rotating anode operated at 50 kV and
40 mA. Using the R-AXIS IIc detector, 90 oscillation photos with a
rotation angle of 2° were collected and processed using the Crys-
talClear software package. An empirical absorption correction was
applied using the REQAB program under CrystalClear. All struc-
tures were solved by direct methods (SIR 97) (Altomare et al.,
1999) and reﬁned using full-matrix least-squares calculations on
F2 (SHELXL-97) (Sheldrick, 2007) operating in the WinGX program
package. Anisotropic thermal displacement parameters were re-
ﬁned for all the non-hydrogen atoms. Hydrogen atoms were in-
cluded in calculated positions and reﬁned using a riding model.
Displacement ellipsoids are drawn with ORTEP-3 for Windows
under WinGX.
2.5. Acetylation
A 20 mg portion of compound 8 or 10 was dissolved in 1 mL
pyridine and then 1 mL acetic anhydride was added. The mixture
was stirred overnight, and subsequently methanol was added and
the solvent was removed under vacuum. The acetate precipitated
by addition of water while stirring briskly, and it was ﬁltered and
dried. The procedure yielded niloticin acetate (17, 5 mg) and pis-
cidinol A diacetate (18, 7 mg), respectively.3. Results and discussion
3.1. Antiplasmodial and cytotoxic activities
The crude extracts of T. nilotica and T. robusta were evaluated
for antiplasmodial activity against the chloroquine-resistant (W2)
and chloroquine-sensitive (D6) Plasmodium falciparum strains
(Table 1). The stem bark of T. robusta showed high antiplasmodial
activity with IC50 2.870.02 μg/mL and 2.370.05 μg/mL against
the W2 and D6 strains, respectively. The stem and root barks of T.
nilotica also displayed considerable antiplasmodial activities
(IC50o10 μg/ml) while its leaves showed only moderate activity.
Cytotoxicity of these extracts was evaluated against three
mammalian cell lines, namely African green monkey kidney
(vero), mouse breast cancer (4T1) and human larynx carcinoma
(HEp2) (Table 1). The stem bark extract of T. robusta was cytotoxic
against the 4T1 and the HEp2 cells (IC50o10 μg/ml), whereas the
extract of T. nilotica possessed moderate cytotoxicity against the
three cell lines studied. Notably, all the extracts had low selectivity
index (o 10), deﬁned as the ratio of IC50 vero cells to IC50 P. fal-
ciparum (D6). This may indicate that the good to moderate anti-
plasmodial activity observed for the above extracts may be due to
their general cytotoxicity. The fractions obtained from the crude
extracts were evaluated for their cytotoxicity against vero cells.
Generally, they had lower cytotoxicity than the crude extracts.
Except for fraction TN12 (IC50¼4.3470.04 μg/mL), most fractions
showed moderate cytotoxicity.
From the stem bark of T. robusta Gũrke six known compounds
were isolated: three ring A-D-intact limonoids, namely azadirone
(1), 12α-acetoxy-7-deacetylazadirone (2) and mzikonone (3), and
the ring B seco limonoid 11-epi-toonacilin (4) (Fig. 1). In addition, it
gave two other triterpenoids azadironolide (5) and turranolide (6).
Compound 5 was isolated as an epimeric mixture, indicated by
doubling of some of its NMR signals. Epimeric mixtures of limo-
noids having a hemiacetal functionality in place of a furan ring
Table 1
Antiplasmodial and cytotoxic activities of selected plant parts.
Plant (part) IC50 (lg/mL) SI
W2 D6 Vero 4T1 Hep2
T. robusta (SB) 2.870.0 2.370.1 21.972.0 5.370.6 4.271.0 9.5
T. nilotica (SB) 7.370.1 6.970.0 17.771.3 ND 22.474.4 2.6
T. nilotica (RB) 9.571.0 7.971.0 13.772.0 18.671.2 27.273.6 1.7
T. nilotica (L) 59.074.0 47.473.0 21.572.0 39.174.0 37.471.3 0.5
Chloroquine a,108.070.1 a,7.770.0 43.970.5 ND ND 5701
SB: stem bark, RB: root bark, L: leaves, SI: selectivity index [IC50 vero/IC50 (D6)]; Positive control: podophyllum resin, IC50 (4T1)¼0.4770.05 mg/mL melarsoprol IC50 (Vero)¼
0.7670.01 mg/mL;
a IC50: half maximal inhibitory concentration given in nM for chloroquine. ND: not determined, due to the small sample amount available.
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McFarland et al., 2004). The secondary metabolite content of T.
robusta stem bark was similar to those reported for other Turraea
species, which have limonoids as the main constituents. Com-
pounds 2 and 4 were reported from this species for the ﬁrst time.
This is the ﬁrst report on the occurrence of compound 5 in the
genus Turraea.
From the root bark of T. nilotica, four limonoids azadirone (1),
12α-acetoxy-7-deacetylazadirone (2), mzikonone (3), (Fig. 1) and
1α,3α-diacety-7α-tigloyvilasinin (7) (Fig. 2) were isolated. From
its stem bark, four protolimonoids niloticin (8), hispidol B (9),
piscidinol A (10) and toonapubesin F (11) were isolated. A mixture
of sitosterol-3-O-β-D-glucopyranoside acetate (12) and stigmas-
terol-3-O-β-D-glucopyranoside acetate (13), sitosterol-3-O-β-D-
glucopyranoside (14) as well as a mixture of β-sitosterol (15) and
stigmasterol (16) were isolated from the leaves. Compounds 1, 2, 3,
7 and 9 are reported here from this species for the ﬁrst time. There
is no previous report on compounds 11-14 from the genus Turraea.
The structure of toonapubesin F (11), ﬁrst isolated from Toona
ciliate var. pubesins (Wang et al., 2011), was further conﬁrmed by
an X-ray crystallographic analysis (Fig. 3) from a single crystal
obtained by slow crystallization from a mixture of di-
chloromethane and acetone. The atomic coordinates are given in
the Supplementary Information.
As the stereochemistry of the toonapubesin backbone is knownO
R1H
H
O
O COOMe
AcO
AcO
H
H O
O
H
H
4 5
R1 R2
1 OAc H
2 OH OA
R2
O
Fig. 1. The structures of the limonoids azadirone (1), 12α-acetoxy-7-deacetylazadiron
terpenoids azadironolide (5), and turranolide (6), isolated from the stem bark of Turrae(Wang et al., 2011), the chirogenic center at C4 is (S). Hence, this
data allows identiﬁcation of the oxidized methyl functionality on
C4, i.e. C25 and not C24 ( Fig. 3).
The roots, stem and leaves of T. nilotica, were found to contain
different secondary metabolites. Limonoids were isolated from the
root bark, and protolimonoids from the stem bark while phytos-
terols were isolated from the leaves. Limonoids, protolimonoids
and steroids share a tetracyclic triterpenoid skeleton; however,
they differ in the oxidation state of their side chain. Based on the
previously proposed biosynthetic pathway of limonoids, (Cham-
pagne et al., 1992; Tan and Luo, 2011) T. nilotica is likely to follow
the phytosterol (leaves)-protolimonoid (stem bark)-limonoid
(root bark) biosynthetic pathway.
The antiplasmodial potency of some limonoids and other tri-
terpenoids has been previously reported (Maneerat et al., 2008;
Mohamad et al., 2009). Therefore, some of the compounds isolated
in this work were tested for antiplasmodial activities against the
D6 and W2 Plasmodium falciparum strains (Table 2). Their activity
was scored according to the classiﬁcation of Batista et al. (2009),
where IC50o1 μM is highly active; 1r IC50r20 μM is active,
20 μMr IC50r100 μM is moderately active, and IC504100 is in-
active. Of the eight compounds tested, two showed good activity
with the most active substance being the epimeric mixture aza-
dironolide (5) (IC50o2.4 μM), and six showed moderate activities
against the W2 and D6 strains (Table 2). The antiplasmodialO
O
H
H
O
OAcOAc
O OH
AcO
H
H
6
3c
O
HO
O
O
e (2), and mzikonone (3), the ring B seco limonoid 11-epi-toonacilin (4), the tri-
a robusta.
Fig. 2. In addition to 1–3 shown in Fig. 1, the limonoid 1α,3α-diacety-7α-tigloyvilasinin (7), the protolimonoids niloticin (8), hispidol B (9), piscidinol A (10) and toonapubesin
F (11), the phytosterols sitosterol-3-O-β-D-glucopyranoside acetate (12), stigmasterol-3-O-β-D-glucopyranoside acetate (13), and sitosterol-3-O-β-D-glucopyranoside (14)
were isolated from the root and stem barks of Turraea nilotica.
O2 C25
C24
C4
O1
C3
C2 C1
C26 C10
C5
C6 C7
C8
C9
C11 C12
C14
C28
C15
C16
C17
C27
C13 C18
C29
C19
C20
C21
O3
C23
C22
C30
O5
O4
Fig. 3. ORTEP picture of toonapubesin F (11). All nonpolar hydrogens have been
omitted for clarity. Displacement ellipsoids are drawn at the 50% probability level.
Fig. 4. The structure of niloticin acetate (17) and piscidinol A diacetate (18).
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ture data (Chianese et al., 2010).
The isolated compounds were also tested for cytotoxicity
(Table 2) against the mammalian cell line African green monkey
kidney (vero cells). Most of them showed moderate cytotoxicity
(IC50420 μM) and a low selectivity index [SI¼ IC50(vero)/IC50
(D6)o10]. Thus, the observed moderate antiplasmodial activity of
these compounds is likely due to general cytotoxicity, rather than
due to a speciﬁc activity against the Plasmodium parasite. It should,
however, be noted that compounds 4 and 5 that are classiﬁed as
active, were observed to have comparably high selectivity index
SI410.5 and 11.5, respectively, though signiﬁcantly lower thanTable 2
Antiplasmodial and cytotoxic activities (IC50 in μM) of compounds isolated from Turraea
Compound D6 W2
Azadirone (1) 23.470.2 29.671.0
12α-Acetoxy-7-deacetylazadirone (2) 31.070.2 30.270.5
Mzikonone (3) 36.670.8 40.573.7
11-epi-Toonacilin (4) 17.170.2 14.470.5
Azadironolide (5) 2.470.0 1.170.0
Niloticin (8) 48.272.3 77.075.7
Hispidol B (9) 36.872.0 37.273.2
Piscidinol A (10) 37.671.4 36.374.4
Niloticin acetate (15) 68.375.3 172.974.5
Piscidinol A acetate (16) ND ND
Chloroquine 7.770.02c 108.070.1c
The mean values of at least three independent experiments are reported. ND: not deter
a SI¼ IC50 (vero)/IC50(D6).
b Values4100 ug/ml not cytotoxic, Positive control: podophyllum resin, IC50 (4T1)¼
c IC50: half maximal inhibitory concentration given in nM for chloroquine.chloroquine (SI¼5702).
Although the investigated plants are in traditional medicinal
use against malaria, and their crude extracts showed promising
antimalarial activities, their isolated metabolites did not display
considerable activity against P. falciparum. This may be explained
by synergetic effects or by the loss of one or some minor yet highly
active metabolites during the puriﬁcation process. For an im-
proved understanding of the traditional medicinal applicability of
these plants further studies are necessary.
Some limonoids and protolimonoids isolated from other plants
were previously reported to possess substantial cytotoxicity
(Maneerat et al., 2008), which, along with the high to moderate
cytotoxicity of the crude extracts and isolated compounds against
‘normal’ vero cells motivated the evaluation of cytotoxicity of the
isolated constituents against the cancerous cell lines 4T1 and HEp2
(Table 2).
Compounds 1, 5, 8–10 showed high cytotoxicities against thenilotica and Turraea robusta.
4T1 HEp2 Vero SIa
14.470.0 12.870.0 4229.4b 49.8
104.677.1 40.372.2 134.172.9 4.3
38.870.4 59.371.0 139.674.7 3.8
88.673.2 68.171.3 4180.5b 410.5
14.770.2 8.570.5 27.670.6 11.5
14.570.5 6.970.6 14.570.4 0.3
21.773.2 7.470.7 130.073.1 3.5
8.070.0 8.470.0 41.175.8 1.1
ND 121.970.1 4200.8b ND
ND 15.270.8 4179.2b ND
ND ND 43.970.5 5701
mined, due to the small amount of sample available.
0.4770.05 mg/mL, melarsoprol IC50 (Vero)¼0.7670.01 mg/mL.
Table 3
Occurrence of some limonoids in Turraea species.
Limonoid Turraea species
Azadirone (1) T. nilotica T. robusta – – –
12α-acetoxy-7-deacetylazadirone (2) T. robusta T. cornucopia T. pubescens – –
Mzikonone (3) T. robusta T. cornucopia T. parvifolia T. nilotica T. pubescens
11-epi-toonacilin (4) T. robusta T. holstii T. pubescens T. cornucopia –
1α,3α-diacety-7α-tigloyvilasinin (7) T. nilotica T. parvifolia – – –
B.N. Irungu et al. / Journal of Ethnopharmacology 174 (2015) 419–4254244T1 and HEp2 cell lines with IC50o20 mM. It should be stressed
that these compounds showed moderate cytotoxicity against
‘normal’ vero cells, yet high cytotoxicity against cancerous cell
lines. Hence these compounds may be promising leads for devel-
opment of anticancer agents (Diantini et al., 2012).
For assessment of the importance of the free hydroxyl groups of
compound 8 and 10 on their bioactivities, they were acetylated to
give niloticin acetate (17) and piscidinol A diacetate (18), respec-
tively (Fig. 4). The acetate derivatives 17 and 18 showed lower
cytotoxicity as compared to the parent, non-acetylated compounds
8 and 10, indicating the importance of free hydroxyl group(s) in
the side chain. A reduction in antiplasmodial activity of compound
17 in comparison to the parent compound 8 was also observed.
3.2. The chemotaxonomic signiﬁcance of Turraea limonoids
Various classes of limonoids were reported from the genus
Turraea with each species synthesizing more than one class of li-
monoids. Ring intact limonoids were reported from eight Turraea
species, namely T. robusta, T. nilotica, T. cornucopia, T. parvifolia, T.
ﬂoribunda, T. holstii, T. wakeﬁeldii and T. pubescens (Bentley et al.,
1992; Ndung'u et al., 2004; Owino et al., 2008; Yuan et al., 2013).
So far, ring A seco limonoids have only been isolated from T. wa-
keﬁeldii (Ndung'u et al., 2003), whereas ring B seco limonoids were
reported in T. ﬂoribunda, T. holstii and T. pubescens (Mulholland
et al., 1998; McFarland et al., 2004; Yuan et al., 2013). Ring A-B seco
limonoids were reported from T. mombassana and T. obtusifolia,
while ring C seco limonoids from T. holstii and T. pubescens (Adul
et al., 1993; Sarker et al., 1997; Mulholland et al., 1998; Yuan et al.,
2013). Interestingly, so far no ring D seco limonoid was reported
from the genus Turraea although several examples were isolated
from other Meliacea genera. The presence of compounds 1-4 and 7
in T. robusta and T. nilotica is in line with the fact that limonoids
are common constituents of the genus Turraea. Except for com-
pound 1 that was reported from other genera of the Meliacea fa-
mily (Zhou et al., 1997), the limonoids disclosed here have not
been reported from any other genus. The occurrence of ﬁve li-
monoids in Turraea species is shown in Table 3, among which 3
was isolated from ﬁve species.4. Conclusion
Six compounds were isolated from the stem bark of Turraea
robusta. Four of them were limonoids and two of them triterpe-
noids. Of these six compounds, azadironolide (5) is new to the
genus. The secondary metabolites present in the stem bark were
also found in the root bark. Compound 3 is a common limonoid in
the genus Turraea, and was previously reported from ﬁve Turraea
species (Cheplogoi and Mulholland, 2003; Owino et al., 2008;
Yuan et al., 2013). From the leaves, root and stem bark of Turraea
nilotica twelve compounds were isolated. Toonapubesin F (11),
sitosterol 3- O-β-D-glucopyranoside acetate (12), stigmasterol-
3- O-β-D-glucopyranoside acetate (13) and sitosterol-3-O-β-D-
glucopyranoside (14) are new to the genus. Different secondary
metabolites were observed in the leaves, and thus the roots andthe stem were observed to contain limonoids and protolimonoids,
whereas the leaves contained phytosterols.
Out of the isolated compounds, 11-epi-toonacilin (4) and aza-
dironolide (5) showed good antiplasmodial activity with the
highest selectivity indices among the isolated compounds. Aza-
dironolide (5), niloticin (8), hispidol B (9) and piscidol A (10) were
cytotoxic to HEp2 and 4T1 cells with IC50o20 μM. The cytotoxi-
city of the latter constituents against the ‘normal’ vero cell line
was comparably low, indicating some degree of selectivity.Acknowledgments
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